A small device that both detects the initial signal of an epileptic attack and doses a substance that effectively stops it has been developed by researchers at Linkeping University in collaboration with French colleagues. All this takes place where the signal arises, known as a "neural pixel".
The results, from the Laboratory for Organic Electronics at LiU's Campus Norrkeping, have been published in the prestigious journal Proceedings of the National Academy of Sciences (PNAS), with Asst. Prof. Daniel Simon as main author.
Epilepsy
Fits or convulsions or Epilepsy is characterized by recurrent, involuntary seizures and is described as a chronic neurological disorder
Advertisement
‘A small device that both detects the initial signal of an epileptic attack and doses a substance that effectively stops it has been developed.’
Tweet it Now
A recently produced estimate suggests that no less than 6% of the Earth's population suffers from some type of neurological illness such as epilepsy or Parkinson's. Some medicines are available, but when these are taken orally or injected into the bloodstream, they also end up where they aren't needed and may cause serious problems. All medicines have more or less severe side effects, and no fully satisfactory treatment for neurological illnesses is available.
Neurons, or nerve cells, are the cells in the body that both transmit and receive nerve impulses. The small device developed by the scientists can both capture signals and stop them in the exact area of nerve cells where they arise. No other part of the body needs to be involved.
![Sleep Disorders Associated with Epilepsy]( "Sleep Disorders Associated with Epilepsy")
Epilepsy and sleep disorders have a profound effect on each other. Epileptic seizures can disturb sleep; sleep disorders like sleep apnea, RLS can aggravate seizures.
"Our technology makes it possible to interact with both healthy and sick neurons. We can now start investigating opportunities for finding therapies for neurological illnesses that arise so rapidly and so locally that the patient doesn't notice them," says Daniel Simon.
The experiments were conducted in the laboratory on slices of brains from mice. The device consists of a sensor that detects nerve signals, and a small ion pump that doses an exact amount of the neurotransmitter GABA, a substance the body itself uses to inhibit stimuli in the central nervous system.
"The same electrode that registers the activity in the cell can also deliver the transmitter. We call it a bioelectronic 'neural pixel', since it imitates the functions of biological neurons," says Daniel Simon.
"Signalling in biological systems is based on chemical signals in the form of cations, which are passed between transmitters and receptors, which consist of proteins. When a signal is transferred to another cell, the identification of the signal and the triggering of a new one occur within a very small distance - only a few nanometers. In certain cases, it happens at the same point. That's why being able to combine electronic detection and release in the same electrode is a major advance," says Professor Magnus Berggren.
The small ion pump, which was developed at the Laboratory for Organic Electronics, attracted a great deal of attention when it's first application as a therapeutic device was published a year ago. The sensor that captures the nerve signal has subsequently been developed by the LiU researchers' collaborators. The mouse experiments were performed at Aix-Marseille University. The entire device is manufactured from conductive, biocompatible plastic.
Source: Eurekalert
Sleep Disorders Associated with Epilepsy
Epilepsy and sleep disorders have a profound effect on each other. Epileptic seizures can disturb sleep; sleep disorders like sleep apnea, RLS can aggravate seizures.
Advertisement
"Our technology makes it possible to interact with both healthy and sick neurons. We can now start investigating opportunities for finding therapies for neurological illnesses that arise so rapidly and so locally that the patient doesn't notice them," says Daniel Simon.
The experiments were conducted in the laboratory on slices of brains from mice. The device consists of a sensor that detects nerve signals, and a small ion pump that doses an exact amount of the neurotransmitter GABA, a substance the body itself uses to inhibit stimuli in the central nervous system.
"The same electrode that registers the activity in the cell can also deliver the transmitter. We call it a bioelectronic 'neural pixel', since it imitates the functions of biological neurons," says Daniel Simon.
"Signalling in biological systems is based on chemical signals in the form of cations, which are passed between transmitters and receptors, which consist of proteins. When a signal is transferred to another cell, the identification of the signal and the triggering of a new one occur within a very small distance - only a few nanometers. In certain cases, it happens at the same point. That's why being able to combine electronic detection and release in the same electrode is a major advance," says Professor Magnus Berggren.
The small ion pump, which was developed at the Laboratory for Organic Electronics, attracted a great deal of attention when it's first application as a therapeutic device was published a year ago. The sensor that captures the nerve signal has subsequently been developed by the LiU researchers' collaborators. The mouse experiments were performed at Aix-Marseille University. The entire device is manufactured from conductive, biocompatible plastic.
Source: Eurekalert
Indian NGO Urges the Government to Frame National Program to Tackle Epilepsy
There is an urgent need to frame and implement a national policy to control and treat epilepsy that affects over 12 million people in India.
Advertisement
Australian Scientists Discover Treatment for Epilepsy That Affects Only Young GirlsAmerican company, Marinus Pharmaceuticals, is now recruiting affected girls as part of the world's first clinical trial to test the therapy. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
Located at the South Col, the rocky area between Mount Everest and Lhotse serves as the final campsite for climbers as well as a frozen legacy of hardy microbes.
The new finding is found to be valuable for screening specific medications and treatment against Giardia and other protozoan parasites.
New CRISPR genome-editing strategy was found to have a positive impact in the treatment of inherited retinal diseases such as retinitis pigmentosa.
H3N2 Influenza: The newly developed RT-qPCR Kit to identify influenza, COVID-19 and respiratory virus has got approval from ICMR.
Does hormone replacement therapy help rheumatoid arthritis? Yes, the use of exogenous sex hormones is associated with remission in perimenopausal female patients.